Clinical expression of familial hypercholesterolemia in clusters of mutations of the LDL receptor gene that cause a receptor-defective or receptor-negative phenotype

被引:106
作者
Bertolini, S
Cantafora, A
Averna, M
Cortese, C
Motti, C
Martini, S
Pes, G
Postiglione, A
Stefanutti, C
Blotta, I
Pisciotta, L
Rolleri, M
Langheim, S
Ghisellini, M
Rabbone, I
Calandra, S
机构
[1] Univ Modena, Dept Biomed Sci, I-41100 Modena, Italy
[2] Univ Rome, Inst Med Therapy, Rome, Italy
[3] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy
[4] Univ Sassari, Inst Clin Biochem, I-07100 Sassari, Italy
[5] Univ Padua, Dept Med Sci, Padua, Italy
[6] Univ Roma Tor Vergata, Dept Internal Med, Rome, Italy
[7] Univ Palermo, Inst Internal Med, Palermo, Italy
[8] Natl Inst Hlth, Rome, Italy
[9] Univ Genoa, Dept Internal Med, Genoa, Italy
关键词
LDL receptor gene mutations; familial hypercholesterolemia; mutation clusters; receptor phenotype and clinical expression;
D O I
10.1161/01.ATV.20.9.e41
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Seventy-one mutations of the low density lipoprotein (LDL) receptor gene were identified in 282 unrelated Italian familial hypercholesterolemia (FH) heterozygotes. By extending genotype analysis to families of the index cases, we identified 12 mutation clusters and localized them in specific areas of Italy. To evaluate the impact of these mutations on the clinical expression of FH, the clusters were separated into 2 groups: receptor-defective and receptor-negative, according to the LDL receptor defect caused by each mutation. These 2 groups were comparable in terms of the patients' age, sex distribution, body mass index, arterial hypertension, and smoking status. In receptor-negative subjects, LDL cholesterol was higher (+18%) and high density lipoprotein cholesterol lower (-5%) than the values found in receptor-defective subjects. The prevalence of tendon xanthomas and coronary artery disease (CAD) was 2-fold higher in receptor-negative subjects. In patients >30 years of age in both groups, the presence of CAD was related to age, arterial hypertension, previous smoking, and LDL cholesterol level. Independent contributors to CAD in the receptor-defective subjects were male sex, arterial hypertension, and LDL cholesterol level; in the receptor-negative subjects, the first 2 variables were strong predictors of CAD, whereas the LDL cholesterol level had a lower impact than in receptor-defective subjects. Overall, in receptor-negative subjects, the risk of CAD was 2.6-fold that of receptor-defective subjects. Wide interindividual variability in LDL cholesterol levels was found in each cluster. Apolipoprotein E genotype analysis showed a lowering effect of the epsilon 2 allele and a raising effect of the epsilon 4 allele on the LDL cholesterol level in both groups; however, the apolipoprotein E genotype accounted for only 4% of the variation in LDL cholesterol. Haplotype analysis showed that all families of the major dusters shared the same intragenic haplotype cosegregating with the mutation, thus suggesting the presence of common ancestors.
引用
收藏
页码:E41 / E52
页数:12
相关论文
共 50 条
  • [31] Screening for point mutations in the LDL receptor gene in Bulgarian patients with severe hypercholesterolemia
    Vassil A. Mihaylov
    Anelia D. Horvath
    Alexey S. Savov
    Elina F. Kurshelova
    Ivanka D. Paskaleva
    Assen R. Goudev
    Ivaylo R. Stoilov
    Varban S. Ganev
    Journal of Human Genetics, 2004, 49 : 173 - 176
  • [32] FAMILIAL HYPERCHOLESTEROLEMIA CAUSED BY A NONSENSE MUTATION IN CODON-329 OF THE LDL RECEPTOR GENE
    SOLBERG, K
    RODNINGEN, OK
    TONSTAD, S
    OSE, L
    LEREN, TP
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1994, 54 (08) : 605 - 609
  • [33] Seven DNA polymorphisms in the LDL receptor gene: Application to the study of familial hypercholesterolemia in Spain
    Chaves, FJ
    Puig, O
    GarciaSogo, M
    Real, J
    Gil, JV
    Ascaso, J
    Carmena, R
    Armengod, ME
    CLINICAL GENETICS, 1996, 50 (01) : 28 - 35
  • [34] Familial hypercholesterolemia in Utah kindred with novel R103W mutations in exon 4 of the LDL receptor gene
    Katsumata, H
    Emi, M
    Nobe, Y
    Nakajima, T
    Hirayama, T
    Wu, LL
    Stephenson, SH
    Hopkins, PN
    Williams, RR
    JAPANESE HEART JOURNAL, 1999, 40 (04): : 443 - 449
  • [35] The Trp(23)-Stop and Trp(66)-Gly mutations in the LDL receptor gene: Common causes of familial hypercholesterolemia in Denmark
    Jensen, HK
    Jensen, LG
    Hansen, PS
    Faergeman, O
    Gregersen, N
    ATHEROSCLEROSIS, 1996, 120 (1-2) : 57 - 65
  • [36] IDENTIFICATION OF RECURRENT AND NOVEL MUTATIONS IN EXON 4 OF THE LDL RECEPTOR GENE IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE UNITED-KINGDOM
    GUDNASON, V
    KINGUNDERWOOD, L
    SEED, M
    SUN, XM
    SOUTAR, AK
    HUMPHRIES, SE
    ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (01): : 56 - 63
  • [37] Mutation Analysis in 36 Unrelated Spanish Subjects with Familial Hypercholesterolemia: Identification of 3 Novel Mutations in the LDL Receptor Gene
    Mozas, Pilar
    Cenarro, Ana
    Civeira, Fernando
    Castillo, Sergio
    Ros, Emilio
    Pocovi, Miguel
    HUMAN MUTATION, 2000, 15 (05)
  • [38] Five familial hypercholesterolemic kindreds in Japan with novel mutations of the LDL receptor gene
    Hirayama, T
    Yamaki, E
    Hata, A
    Tsuji, M
    Hashimoto, K
    Yamamoto, M
    Emi, M
    JOURNAL OF HUMAN GENETICS, 1998, 43 (04) : 250 - 254
  • [39] Five familial hypercholesterolemic kindreds in Japan with novel mutations of the LDL receptor gene
    Tsunenori Hirayama
    E. Yamaki
    Akira Hata
    Masahiro Tsuji
    Kiyoshi Hashimoto
    Masao Yamamoto
    M. Emi
    Journal of Human Genetics, 1998, 43 : 250 - 254
  • [40] FH AFRIKANER-3 LDL RECEPTOR MUTATION RESULTS IN DEFECTIVE LDL RECEPTORS AND CAUSES A MILD FORM OF FAMILIAL HYPERCHOLESTEROLEMIA
    VANROGGEN, JFG
    VANDERWESTHUYZEN, DR
    COETZEE, GA
    MARAIS, AD
    STEYN, K
    LANGENHOVEN, E
    KOTZE, MJ
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (06) : 765 - 772